company background image
SLNG

SLANG Worldwide CNSX:SLNG Stock Report

Last Price

CA$0.085

Market Cap

CA$8.4m

7D

-5.6%

1Y

-92.7%

Updated

10 Aug, 2022

Data

Company Financials
SLNG fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

SLNG Stock Overview

SLANG Worldwide Inc. operates as a cannabis consumer packaged goods company in Canada and the United States.

SLANG Worldwide Competitors

Price History & Performance

Summary of all time highs, changes and price drops for SLANG Worldwide
Historical stock prices
Current Share PriceCA$0.085
52 Week HighCA$1.29
52 Week LowCA$0.05
Beta1.32
1 Month Change6.25%
3 Month Change-43.33%
1 Year Change-92.74%
3 Year Change-98.81%
5 Year Changen/a
Change since IPO-99.29%

Recent News & Updates

Shareholder Returns

SLNGCA PharmaceuticalsCA Market
7D-5.6%0.04%0.3%
1Y-92.7%-66.8%-2.0%

Return vs Industry: SLNG underperformed the Canadian Pharmaceuticals industry which returned -66.8% over the past year.

Return vs Market: SLNG underperformed the Canadian Market which returned -2% over the past year.

Price Volatility

Is SLNG's price volatile compared to industry and market?
SLNG volatility
SLNG Average Weekly Movement26.1%
Pharmaceuticals Industry Average Movement13.4%
Market Average Movement10.8%
10% most volatile stocks in CA Market19.4%
10% least volatile stocks in CA Market4.3%

Stable Share Price: SLNG is more volatile than 90% of Canadian stocks over the past 3 months, typically moving +/- 26% a week.

Volatility Over Time: SLNG's weekly volatility has increased from 21% to 26% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2017n/aMark McManiglehttps://slangww.com

SLANG Worldwide Inc. operates as a cannabis consumer packaged goods company in Canada and the United States. It owns, licenses, and/or markets 10 brands which serve flower, inhalable concentrate, and ingestible. SLANG Worldwide Inc. has a strategic partnership with Trulieve Cannabis Corp. to supply branded cannabis products in Massachusetts.

SLANG Worldwide Fundamentals Summary

How do SLANG Worldwide's earnings and revenue compare to its market cap?
SLNG fundamental statistics
Market CapCA$8.36m
Earnings (TTM)-CA$48.00m
Revenue (TTM)CA$36.75m

0.2x

P/S Ratio

-0.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SLNG income statement (TTM)
RevenueCA$36.75m
Cost of RevenueCA$22.01m
Gross ProfitCA$14.74m
Other ExpensesCA$62.74m
Earnings-CA$48.00m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.49
Gross Margin40.12%
Net Profit Margin-130.59%
Debt/Equity Ratio30.0%

How did SLNG perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is SLNG undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SLNG?

Other financial metrics that can be useful for relative valuation.

SLNG key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.3x
Enterprise Value/EBITDA-0.7x
PEG Ration/a

Price to Sales Ratio vs Peers

How does SLNG's PS Ratio compare to its peers?

SLNG PS Ratio vs Peers
The above table shows the PS ratio for SLNG vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average1.8x
FLWR Flowr
0.7xn/aCA$8.7m
AQS Aequus Pharmaceuticals
3.2xn/aCA$8.0m
MRV Nuvo Pharmaceuticals
0.1x-2.7%CA$7.7m
THC THC Biomed Intl
3.3xn/aCA$8.2m
SLNG SLANG Worldwide
0.2xn/aCA$8.4m

Price-To-Sales vs Peers: SLNG is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (1.8x).


Price to Earnings Ratio vs Industry

How does SLNG's PE Ratio compare vs other companies in the CA Pharmaceuticals Industry?

Price-To-Sales vs Industry: SLNG is good value based on its Price-To-Sales Ratio (0.2x) compared to the Canadian Pharmaceuticals industry average (1.8x)


Price to Sales Ratio vs Fair Ratio

What is SLNG's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SLNG PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.2x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate SLNG's Price-To-Sales Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of SLNG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate SLNG's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate SLNG's fair value for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies

Future Growth

How is SLANG Worldwide forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


75.9%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as SLANG Worldwide has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Discover growth companies

  • Examine SLANG Worldwide's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • SLANG Worldwide competitive advantages and company strategy can generally be found in its financial reports archived here.

Past Performance

How has SLANG Worldwide performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-14.8%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: SLNG is currently unprofitable.

Growing Profit Margin: SLNG is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: SLNG is unprofitable, and losses have increased over the past 5 years at a rate of 14.8% per year.

Accelerating Growth: Unable to compare SLNG's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SLNG is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (72.5%).


Return on Equity

High ROE: SLNG has a negative Return on Equity (-139.96%), as it is currently unprofitable.


Discover strong past performing companies

Financial Health

How is SLANG Worldwide's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: SLNG's short term assets (CA$35.2M) exceed its short term liabilities (CA$13.2M).

Long Term Liabilities: SLNG's short term assets (CA$35.2M) exceed its long term liabilities (CA$24.4M).


Debt to Equity History and Analysis

Debt Level: SLNG has more cash than its total debt.

Reducing Debt: Insufficient data to determine if SLNG's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SLNG has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: SLNG has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 18.6% each year.


Discover healthy companies

Dividend

What is SLANG Worldwide current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate SLNG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate SLNG's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if SLNG's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SLNG's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as SLNG has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

2.0yrs

Average management tenure


CEO

Mark McManigle (66 yo)

0.75

Tenure

CA$56,408

Compensation

Mr. Mark Drew McManigle serves as an Interim Chief Executive Officer and Chairman of the Board at SLANG Worldwide Inc since November 15, 2021. He has been Southwest Regional Head at SierraConstellation Par...


CEO Compensation Analysis

Compensation vs Market: Mark's total compensation ($USD44.20K) is below average for companies of similar size in the Canadian market ($USD186.28K).

Compensation vs Earnings: Insufficient data to compare Mark's compensation with company performance.


Leadership Team

Experienced Management: SLNG's management team is considered experienced (2 years average tenure).


Board Members

Experienced Board: SLNG's board of directors are not considered experienced ( 0.2 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: SLNG insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 47.4%.


Top Shareholders

Company Information

SLANG Worldwide Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: SLANG Worldwide Inc.
  • Ticker: SLNG
  • Exchange: CNSX
  • Founded: 2017
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: CA$8.363m
  • Shares outstanding: 98.39m
  • Website: https://slangww.com

Location

  • SLANG Worldwide Inc.
  • 50 Carroll Street
  • Toronto
  • Ontario
  • M4M 3G3
  • Canada

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/10 00:00
End of Day Share Price2022/08/10 00:00
Earnings2022/03/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.